Showing results (11-20 of 192) with videos related to
Sort By:
Pageof 20
Cancer Control : Journal of the Moffitt Cancer Center|February 4, 2010
Iron overload in myelodysplastic syndromes: diagnosis and managementAlan F ListCurrent Opinion in Hematology|January 27, 2007
The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromesMagda Melchert, Vishakha Kale, Alan ListBlood|June 26, 2004
Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategiesDaruka Mahadevan, Alan F ListCurrent Hematology Reports|October 20, 2005
Cytokine targets in the treatment of myelodysplastic syndromesAmit Verma, Alan F ListInternational Journal of Hematology|December 7, 2007
Immunomodulatory therapy for myelodysplastic syndromesLubomir Sokol, Alan F ListCurrent Pharmaceutical Biotechnology|November 2, 2006
Immunomodulatory drugs (IMiDs): a new treatment option for myelodysplastic syndromesVishakha Kale, Alan F ListCurrent Pharmaceutical Design|May 11, 2012
Lenalidomide for treatment of myelodysplastic syndromesRami S Komrokji, Alan F ListClinical Lymphoma & Myeloma|June 16, 2009
Durable long-term responses in patients with myelodysplastic syndromes treated with lenalidomideSandra E Kurtin, Alan F ListSeminars in Oncology|September 28, 2011
Role of lenalidomide in the treatment of myelodysplastic syndromesRami S Komrokji, Alan F ListHematology/Oncology Clinics of North America|April 3, 2010
Lenalidomide for treatment of myelodysplastic syndromes: current status and future directionsRami S Komrokji, Alan F ListPageof 20